Consensus Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
79.58 ^USD	+5.52%		+22.56%	+327.62%

Apr. 25	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	MT
Apr. 24	Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	MT

Evolution of the average Target Price on Viking Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

118bcbefa945055d0af.cthgEDAujqIMmPWkKcRe1JMRDJUnIbl3elK9qGYsPMc.GK1NcV1L2ct_yK33H_waoPZbWO9_EYADL2fV5AhiCb0HjwVFAU_g7lXxrA~d97e10625257d7fce36421d626f3ee0a

Analyst Recommendations on Viking Therapeutics, Inc.

Oppenheimer Adjusts Viking Therapeutics Price Target to $138 From $116, Maintains Outperform Rating	Mar. 27	MT
Stifel Adjusts Viking Therapeutics Price Target to $95 From $80, Maintains Buy Rating	Mar. 26	MT
BTIG Raises Price Target on Viking Therapeutics to $100 From $86, Keeps Buy Rating	Mar. 15	MT
Jefferies Starts Viking Therapeutics With Buy Rating, $110 Price Target	Mar. 07	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $116 From $46, Maintains Outperform Rating	Feb. 28	MT
HC Wainwright Raises Price Target on Viking Therapeutics to $90 From $33, Keeps Buy Rating	Feb. 27	MT
Stifel Adjusts Price Target on Viking Therapeutics to $35 From $30, Maintains Buy Rating	Feb. 14	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $46 From $40, Maintains Outperform Rating	Feb. 08	MT
Health Care Down on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	23-07-07	DJ
Raymond James Adjusts Viking Therapeutics Price Target to $37 From $35, Maintains Outperform Rating	23-05-17	MT
Stifel Adjusts Viking Therapeutics' Price Target to $30 From $25, Keeps Buy Rating	23-05-16	MT
BTIG Adjusts Viking Therapeutics' Price Target to $36 From $31, Keeps Buy Rating	23-05-16	MT
Roth MKM Adjusts Price Target on Viking Therapeutics to $24 From $19, Maintains Buy Rating	23-05-03	MT
HC Wainwright Adjusts Price Target on Viking Therapeutics to $33 From $21, Maintains Buy Rating	23-04-27	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $35 From $30, Maintains Outperform Rating	23-04-25	MT
BTIG Research Adjusts Viking Therapeutics Price Target to $31 From $20, Maintains Buy Rating	23-03-29	MT
Raymond James Adjusts Viking Therapeutics Price Target to $35 From $12, Maintains Outperform Rating	23-03-29	MT
Stifel Nicolaus Adjusts Viking Therapeutics Price Target to $25 From $22, Maintains Buy Rating	23-03-28	MT
Stifel Initiates Viking Therapeutics at Buy With $22 Price Target	23-03-17	MT
Raymond James Adjusts Price Target on Viking Therapeutics to $12 From $11, Maintains Outperform Rating	23-02-09	MT
Oppenheimer Adjusts Viking Therapeutics' Price Target to $17 From $15, Maintains Outperform Rating	23-02-09	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $15 From $13, Maintains Outperform Rating	23-01-30	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $13 From $10, Maintains Outperform Rating	22-12-20	MT
Maxim Group Adjusts Viking Therapeutics Price Target to $15 From $10, Maintains Buy Rating	22-12-20	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $10 From $12, Maintains Outperform Rating	22-10-28	MT